Hol dir die App Get the App
⭐️⭐️⭐️⭐️⭐️
44 Bewertungen
Zur App
DAX 25.518,00 -1,35% Dow Jones 52.429,50 -0,64% MDAX 32.012,20 -1,21% Nikkei 225 64.147,50 -1,47% S&P 500 7.638,88 -0,39% STOXX Europe 50 6.298,75 -1,20% Nasdaq 100 29.415,80 -0,21% Bitcoin 78.234,01 USD -0,52% Gold 141,46 USD 1,10% EUR/USD 1,16 USD 0,04%
DAX 25.518,00 -1,35% Dow Jones 52.429,50 -0,64% MDAX 32.012,20 -1,21% Nikkei 225 64.147,50 -1,47% S&P 500 7.638,88 -0,39% STOXX Europe 50 6.298,75 -1,20% Nasdaq 100 29.415,80 -0,21% Bitcoin 78.234,01 USD -0,52% Gold 141,46 USD 1,10% EUR/USD 1,16 USD 0,04%
+49 (0) 172 414 333 6
Wertpapiere

Aktie SE0000163628

Elekta AB (publ)

4,45 €

  • 0,00 €
  • |
  • 0,00 %

Your browser does not support the canvas element.

  • Juni
  • Juli
  • Aug.
  • Sept.
  • 4.05
  • 4.30
  • 4.55
  • 4.79
  • 5.04

ERTRÄGE

Warnung: Die Dividende wurde um 65,1% gekürzt auf 0,11 € pro Aktie. Dies könnte eine strategische Entscheidung sein oder auf veränderte finanzielle Prioritäten hinweisen. Aktionäre sollten prüfen, ob dies ein isolierter Rückschlag oder ein Zeichen struktureller Probleme ist.

0,11 €

Jährliche Dividende

2,48 %

Rendite

  • 0,00 €

    März
  • 0,11 €

    Sept.
  • 0,11 €

    Sept.
  • 0,11 €

    März

-65,07 %

Dividenden-Wachstum

  • 17

  • 18

  • 19

  • 20

  • 21

  • 22

  • 23

  • 24

  • 25

  • 26

45,11 %

Ausschüttungsquote

  • A

    45 %
  • 55 %

    G

  • A

    4 %
  • 96 %

    OCF

Historische Dividenden

    • 0,00 %
    • 0,00 €
    2019
    • 0,69 %
    • 0,08 €
    2020
    • 0,86 %
    • 0,11 €
    2021
    • 0,00 %
    • 0,00 €
    2022
    • 0,00 %
    • 0,00 €
    2023
    • 2,93 %
    • 0,19 €
    2024
    • 2,54 %
    • 0,11 €
    2025
    • 2,45 %
    • 0,11 €
    2026

UNTERNEHMEN

17,8 Mrd. SEK

Umsatz

  • 274,0 Mio.

    NG

  • 2,7 Mrd.

    F&E

  • 6,7 Mrd.

    BG

  • 17,8 Mrd.

    U

-0,99 %

Umsatz-Wachstum

  • 22

  • 23

  • 24

  • 25

  • 26

274,0 Mio. SEK

Nettogewinn

  • 2,8 %

    ROE
  • 1,5 %

    ROS
  • 0,9 %

    ROA
  • 12,2 %

    GPM

3,0 Mrd. SEK

Operativer Cashflow

  • FCF

    52 %
  • 48 %

    CapEx

9,8 Mrd. SEK

Eigenkapital

  • EK 32 %
  • 68 % FK

4.541

Mitarbeiter

  • 3,9 Mio. SEK

    Umsatz / MA
  • 60.339,1 SEK

    Gewinn / MA

KGV

67,00 SEK

KBV

1,87 SEK

KCV

11,58 SEK

KUV

1,03 SEK

EV/EBITDA

16,65 SEK

EV/EBIT

38,80 SEK

EV/FCF

22,89 SEK

EV/Umsatz

2,03 SEK

EnterpriseValue

36,3 Mrd. SEK

Eigenkapitalrendite

2,79 %

Umsatzrendite

1,54 %

EBIT-Marge

5,24 %

EBITDA-Marge

12,22 %

Kapitalumschlag

0,58 SEK

Gesamtkapitalrendite

0,89 %

Eigenkapitalquote

0,32 SEK

Fremdkapitalquote

0,68 SEK

Verschuldungsgrad

2,15 SEK

Dyn. Verschuldungsgrad

6,95 SEK

Sachinvestitionsquote

-0,15 SEK

Anlagendeckungsgrad 1

1,71 SEK

Anlagendeckungsgrad 2

0,95 SEK

Liquidität 1. Grades

0,24 SEK

Liquidität 2. Grades

0,53 SEK

Liquidität 3. Grades

1,06 SEK

Dividende pro Aktie

0,32 SEK

Dividendenrendite

0,67 %

Ausschüttungsquote

45,11 %

Buchwert pro Aktie

25,65 SEK

Cashflow pro Aktie

7,92 SEK
Stand: 31.07.2025 TTM

Fakten

  • Sitz

    Schweden

  • Hauptsitz

    Stockholm

  • Börsengang

    26.04.2010

  • Ausstehende Aktien

    382,91 Mio.

  • Mitarbeiter

    4,54 Tsd.

  • Währung

    SEK

  • Sektor

    Gesundheitswesen

  • Industrie

    Medical - Instruments & Supplies

  • Börse

    OTC

  • Ticker

    EKTAF

  • Webseite

    elekta.com

Aktie

Unternehmensinfos

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma...
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.